BRPI0513178A - composições para distribuir fármacos altamente solúveis em água - Google Patents

composições para distribuir fármacos altamente solúveis em água

Info

Publication number
BRPI0513178A
BRPI0513178A BRPI0513178-2A BRPI0513178A BRPI0513178A BR PI0513178 A BRPI0513178 A BR PI0513178A BR PI0513178 A BRPI0513178 A BR PI0513178A BR PI0513178 A BRPI0513178 A BR PI0513178A
Authority
BR
Brazil
Prior art keywords
compositions
water soluble
highly water
soluble drugs
dispensing highly
Prior art date
Application number
BRPI0513178-2A
Other languages
English (en)
Inventor
Andrew Xian Chen
Original Assignee
Sd Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sd Pharmaceuticals Inc filed Critical Sd Pharmaceuticals Inc
Publication of BRPI0513178A publication Critical patent/BRPI0513178A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSIçõES PARA DISTRIBUIR FáRMACOS ALTAMENTE SOLúVEIS EM áGUA. A presente invenção fornece composições para distribuir fármacos altamente solúveis em água (tais como alcalóides de vinca), e métodos para usar tais composições.
BRPI0513178-2A 2004-07-12 2005-07-12 composições para distribuir fármacos altamente solúveis em água BRPI0513178A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/889,226 US7871632B2 (en) 2004-07-12 2004-07-12 Compositions for delivering highly water soluble drugs
PCT/US2005/024594 WO2006017246A2 (en) 2004-07-12 2005-07-12 Compositions for delivering highly water soluble drugs

Publications (1)

Publication Number Publication Date
BRPI0513178A true BRPI0513178A (pt) 2008-04-29

Family

ID=35541622

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513178-2A BRPI0513178A (pt) 2004-07-12 2005-07-12 composições para distribuir fármacos altamente solúveis em água

Country Status (18)

Country Link
US (4) US7871632B2 (pt)
EP (1) EP1773294A4 (pt)
JP (1) JP4643641B2 (pt)
KR (1) KR20070032816A (pt)
CN (1) CN1859898B (pt)
AU (1) AU2005271873A1 (pt)
BR (1) BRPI0513178A (pt)
CA (1) CA2578574C (pt)
EA (1) EA012522B1 (pt)
EC (1) ECSP077238A (pt)
IL (1) IL180350A0 (pt)
MA (1) MA29662B1 (pt)
MX (1) MX2007000416A (pt)
NO (1) NO20070785L (pt)
RS (1) RS20070029A (pt)
TW (1) TW200607525A (pt)
WO (1) WO2006017246A2 (pt)
ZA (1) ZA200701167B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1925853B (zh) * 2004-07-28 2011-01-26 陈献 琥珀酸α-生育酚酯及其类似物和盐的稳定注射组合物
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
CN101011355B (zh) * 2006-02-01 2013-01-02 陈献 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途
CN101472562A (zh) * 2006-05-12 2009-07-01 陈献 用于静脉刺激性药物的药物组合物
WO2009078754A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances
WO2009078756A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
US8906855B2 (en) * 2007-12-22 2014-12-09 Vivacelle Bio, Inc. Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US8618056B2 (en) * 2007-12-22 2013-12-31 Cuthbert O. Simpkins Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US8063020B2 (en) * 2007-12-22 2011-11-22 Simpkins Cuthbert O Resuscitation fluid
WO2009108689A1 (en) * 2008-02-25 2009-09-03 Novavax, Inc. Sugar glassified virus like particles (vlps)
US20090286832A1 (en) * 2008-05-15 2009-11-19 Kiichiro Nabeta Narcotic emulsion formulations for treatment of surgical pain
EA201190135A1 (ru) * 2009-02-26 2012-07-30 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Композиции на основе эмульгированных наркотических веществ для лечения боли при раке
CN101879138A (zh) 2009-05-06 2010-11-10 上海恒瑞医药有限公司 长春花生物碱纳米乳剂注射液及其制备方法
CN102573475B (zh) * 2009-08-14 2016-01-20 欧科生医股份有限公司 神经激肽-1拮抗剂的静脉内制剂
NZ608406A (en) * 2010-10-22 2015-06-26 Reddy’S Lab Inc Dr Use of storage stable viscous phospholipid depot to treat wounds
WO2012135856A2 (en) * 2011-04-01 2012-10-04 Spectrum Pharmaceuticals, Inc. Very low dose vinorelbine for treatment of cancer
CN102743337B (zh) * 2011-04-20 2014-04-16 国家纳米科学中心 一种纳米粒子药物组合物及其制备方法
WO2012170796A1 (en) * 2011-06-09 2012-12-13 Amylin Pharmaceuticals, Inc. Gel compositions
WO2013059922A1 (en) 2011-10-25 2013-05-02 The University Of British Columbia Limit size lipid nanoparticles and related methods
EP2846773A4 (en) 2012-05-10 2015-12-30 Painreform Ltd DEPOT FORMULATIONS OF A LOCAL ANESTHETICS AND METHOD FOR THE MANUFACTURE THEREOF
CN105143456A (zh) 2013-03-15 2015-12-09 不列颠哥伦比亚大学 用于转染的脂质纳米粒子和相关方法
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
US20160290093A1 (en) * 2015-04-02 2016-10-06 Baker Hughes Incorporated Disintegrating Compression Set Plug with Short Mandrel
JP6951825B2 (ja) 2015-09-04 2021-10-20 ザ スクリプス リサーチ インスティテュート インスリン免疫グロブリン融合タンパク質
US20240024339A1 (en) * 2020-11-19 2024-01-25 Nippon Kayaku Kabushiki Kaisha Composition containing water-soluble drug causing vascular disorder, solution for use in preparation of administration solution containing water-soluble drug causing vascular disorder, kit, agent for suppressing vascular disorder, and solution containing nonionic surfactant
US12419850B1 (en) 2024-03-21 2025-09-23 GanD, Inc. Bioactive fluid compositions

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US224042A (en) * 1880-02-03 Music-rest for piano-fortes
US670001A (en) * 1900-02-15 1901-03-19 Stephen B Morss Combined curb and gutter.
US4816247A (en) 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
AU630469B2 (en) 1989-05-26 1992-10-29 Abbott Laboratories Injectable clarithromycin composition
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
CA2231682A1 (en) 1995-09-13 1997-03-20 Junzo Seki Pge1-containing freeze-dried preparation and the production thereof
CA2259179C (en) * 1996-07-03 2008-09-23 University Of Pittsburgh Emulsion formulations for hydrophilic active agents
JP3455233B2 (ja) * 1997-04-28 2003-10-14 テキサス・バイオテクノロジー・コーポレイシヨン エンドテリン介在障害治療用のスルホンアミド類
US6723338B1 (en) 1999-04-01 2004-04-20 Inex Pharmaceuticals Corporation Compositions and methods for treating lymphoma
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB9925127D0 (en) 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
JP2003277281A (ja) * 2002-03-20 2003-10-02 Kumamoto Technology & Industry Foundation 静脈炎の予防及び治療のための医薬
US6890558B2 (en) 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
JP4426749B2 (ja) * 2002-07-11 2010-03-03 株式会社産学連携機構九州 Ｏ／ｗ型エマルション製剤
US20050049209A1 (en) * 2003-08-06 2005-03-03 Chen Andrew Xian Pharmaceutical compositions for delivering macrolides
CN1925853B (zh) * 2004-07-28 2011-01-26 陈献 琥珀酸α-生育酚酯及其类似物和盐的稳定注射组合物
CN1634058A (zh) * 2004-10-20 2005-07-06 李晓祥 长春瑞滨乳剂及其制备方法

Also Published As

Publication number Publication date
JP4643641B2 (ja) 2011-03-02
RS20070029A (sr) 2008-11-28
EA200700312A1 (ru) 2007-08-31
WO2006017246A3 (en) 2006-03-30
US20110082168A1 (en) 2011-04-07
EA012522B1 (ru) 2009-10-30
CA2578574C (en) 2013-09-10
HK1100062A1 (en) 2007-09-07
MX2007000416A (es) 2007-03-28
US8026250B2 (en) 2011-09-27
TW200607525A (en) 2006-03-01
US20130029918A1 (en) 2013-01-31
CA2578574A1 (en) 2006-02-16
AU2005271873A1 (en) 2006-02-16
US20060008480A1 (en) 2006-01-12
US8222268B2 (en) 2012-07-17
ZA200701167B (en) 2010-08-25
WO2006017246A2 (en) 2006-02-16
EP1773294A2 (en) 2007-04-18
NO20070785L (no) 2007-04-02
EP1773294A4 (en) 2012-11-21
JP2008505972A (ja) 2008-02-28
MA29662B1 (fr) 2008-08-01
IL180350A0 (en) 2007-06-03
ECSP077238A (es) 2007-04-26
US20120046310A1 (en) 2012-02-23
CN1859898B (zh) 2011-06-08
US7871632B2 (en) 2011-01-18
KR20070032816A (ko) 2007-03-22
CN1859898A (zh) 2006-11-08

Similar Documents

Publication Publication Date Title
BRPI0513178A (pt) composições para distribuir fármacos altamente solúveis em água
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
NO20092611L (no) Krystallinsk faststoff Rasagilin base
SG159547A1 (en) Methods and compositions for modulating hyperstabilized c-met
UY30225A1 (es) Composiciones farmacéuticas
PH12012501811A1 (en) A solid pharmaceutical dosage formulation
TW200614594A (en) Multi-portion socket and related apparatuses
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
ATE530170T1 (de) Paliperidonformulierung mit verzögerter freisetzung
NO20076347L (no) Nye regimer for orale monofasiske befruktningshindrene midler
CL2007002856A1 (es) Compuestos derivados de pirazolo(1,5)pirimidina; composicion farmaceutica qu lo comprende;y su uso para tratar el cancer.
TW200715634A (en) Stable organic devices
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
TW200731974A (en) Transdermal system for verenicline
HRP20080569T3 (en) Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin
PA8624601A1 (es) Macrolidos y metodos para producir los mismos
AR055615A1 (es) Dispersiones amorfas solidas
MA29565B1 (fr) Combinaison de composes de pyrimidylaminobenzamide et imatinib permettant de traiter ou de prevenir les maladies proliferatives
ECSP066486A (es) Antagonistas de receptores de acetilcolina muscarínicos ii
WO2007033374A3 (en) Pharmaceutical compositions and methods using temozolomide and a protein kinase inhibitor
PL380665A1 (pl) Farmaceutyczne kompozycje
EA200602017A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
PL1865931T3 (pl) Plaster przezskórny
TW200631589A (en) Varnish composition based on a solvent of plant origin

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.